Huahui Health
Clinical trials sponsored by Huahui Health, explained in plain language.
-
New hope for advanced liver cancer: experimental drug HH-009 enters trial
Disease control Not yet recruitingThis study tests an experimental drug called HH-009 in people with a specific type of advanced liver cancer (FGF19-positive) that has worsened after other treatments. About 30 participants will receive one of two doses of HH-009 to see if it can slow tumor growth and how safe it …
Phase: PHASE1, PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New cancer drug HH160 enters first human tests for advanced tumors
Disease control Not yet recruitingThis early-phase trial tests a new drug called HH160 in about 56 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. The study is open-label, meaning every…
Phase: PHASE1 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC